Stockscreener 앱 받기
16.26
18.00%
2.48
시장 영업 전:
24.32
8.06
+49.57%
Avalo Therapeutics Inc 주식(AVTX)의 최신 뉴스
Avalo Therapeutics Stock Jumps 33% In Pre-Market Session: Here's Why - Benzinga
Avalo Therapeutics prices $375 million stock offering By Investing.com - Investing.com Australia
Avalo Therapeutics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants - Quiver Quantitative
Avalo prices $375M sale to fund drug development through Phase 3 data - Stock Titan
Avalo Therapeutics announces pricing of $375 million public offering at $17.75 per share - marketscreener.com
Avalo Therapeutics Announces Pricing of $375 Million Public Offering - GlobeNewswire
Avalo Therapeutics Reports Strong Phase 2 Hidradenitis Data - TipRanks
Avalo’s abdakibart meets primary endpoint in hidradenitis trial By Investing.com - Investing.com Australia
Avalo Therapeutics launches public stock offering By Investing.com - Investing.com Australia
Avalo Therapeutics (AVTX) prospectus: stock and pre-funded warrants offering with Phase 2 data - Stock Titan
Avalo Therapeutics stock surges 35% on positive trial data - Investing.com
Avalo Therapeutics launches public stock offering - Investing.com
Avalo launches stock sale to fund Phase 3 abdakibart work - Stock Titan
Avalo's skin disease drug beat placebo in Phase 2, heads to Phase 3 - Stock Titan
Avalo Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewswire
Avalo Therapeutics Achieves Positive Topline Results in Phase 2 LOTUS Trial of Abdakibart (AVTX-009) in Moderate to Severe Hidradenitis Suppurativa - The Manila Times
Strong Phase 2 HS data for abdakibart boosts Avalo Therapeutics (NASDAQ: AVTX) - Stock Titan
Avalo Therapeutics Achieves Positive Topline Results in - GlobeNewswire
This Avalo Therapeutics analyst begins coverage on a bullish note; here are top 5 initiations for Monday - MSN
Jennison Associates LLC Makes New Investment in Avalo Therapeutics, Inc. $AVTX - MarketBeat
Avalo Therapeutics (NASDAQ:AVTX) CFO Sells $111,886.11 in Stock - MarketBeat
Christopher Ryan Sullivan Sells 8,458 Shares of Avalo Therapeutics (NASDAQ:AVTX) Stock - MarketBeat
Avalo Therapeutics (AVTX) CFO trims stake in 10b5-1 share sales - Stock Titan
Insider sale of 16,915 restricted shares (AVTX) - Stock Titan
Oppenheimer reiterates Avalo Therapeutics stock rating at Outperform By Investing.com - Investing.com Australia
Moody Aldrich Partners LLC Buys Shares of 133,231 Avalo Therapeutics, Inc. $AVTX - MarketBeat
Oppenheimer reiterates Avalo Therapeutics stock rating at Outperform - Investing.com
AVTX Q1'26 Earnings: EPS estimate is (1.18) USD - TradingView
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Avalo Therapeutics (AVTX) Secures Milestone Buyout Option with A - GuruFocus
Avalo Therapeutics enters milestone buyout option agreement on April 26SEC filing - marketscreener.com
Avalo Therapeutics Restructures AlmataBio Milestone Payment Obligations - TipRanks
Avalo Therapeutics Purchases Optional Milestone Buyout - The Manila Times
Avalo Therapeutics (NASDAQ: AVTX) adopts optional milestone buyout structure - Stock Titan
Avalo pays $2.25M for 90-day option to replace $15M payout - Stock Titan
Wall Street analysts predict an 113.34% upside in Avalo Therapeutics (AVTX): Here's what you should know - MSN
Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX) and Avalo Therapeutics (AVTX) - The Globe and Mail
Wedbush Maintains Avalo Therapeutics(AVTX.US) With Buy Rating, Maintains Target Price $29 - Moomoo
Avalo (AVTX) Stock: Buy, Sell, Hold? (Smart Money Outflows) 2026-04-15Trend Signals - Cổng thông tin điện tử tỉnh Lào Cai
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Sees Large Increase in Short Interest - MarketBeat
AVTX Reiterated by BTIG -- Price Target Maintained at $40 - GuruFocus
Short Squeeze: Can Avalo Therapeutics Inc grow without external funding2026 Setups & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Breakout Move: Is Avalo Therapeutics Inc a potential multi baggerWeekly Profit Analysis & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Avalo Therapeutics (NASDAQ: AVTX) sets 2026 virtual meeting and ESPP changes - Stock Titan
Death Cross: Will Avalo Therapeutics Inc be affected by tariffsWeekly Loss Report & Daily Profit Focused Screening - baoquankhu1.vn
Wolfe Research initiates coverage of Avalo Therapeutics (AVTX) with outperform recommendation - MSN
AVTX: Wolfe Research Initiates Coverage with 'Outperform' Rating - GuruFocus
Wolfe Research Initiates Avalo Therapeutics(AVTX.US) With Buy Rating, Announces Target Price $48 - Moomoo
Mittie Doyle Sells 3,970 Shares of Avalo Therapeutics (NASDAQ:AVTX) Stock - MarketBeat
Aug Closing: Is Avalo Therapeutics Inc undervalued by DCF analysis2026 Weekly Recap & Daily Chart Pattern Signal Reports - baoquankhu1.vn
Avalo Therapeutics: chief medical officer Doyle Mittie sells $71k in AVTX - Investing.com Canada
Avalo Therapeutics (AVTX) CMO exercises options, sells 3,970 shares in 10b5-1 trades - Stock Titan
Avalo Therapeutics, Inc. (AVTX) stock price, news, quote and history - Yahoo Finance UK
Citizens Initiates Coverage of Avalo Therapeutics (AVTX) with Market Outperform Recommendation - MSN
65,800-share Form 144 filed by AVTX (NASDAQ: AVTX) - Stock Titan
0.14%
0.48%
자본화:
|
볼륨(24시간):